Clinical Trial Update: Palonosetron Versus Ondansetron for PONV Prevention in Patients Undergoing ERCP [Phase 4]

View source ↗

Summary

Clinical trial comparing palonosetron to ondansetron for prevention of postoperative nausea and vomiting in patients undergoing ERCP (Phase 4).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• Ondansetron (ondansetron)
• Palonosetron (palonosetron)

Snippet

Sponsor: Theodor Bilharz Research Institute | Conditions: Antiemetic, Postoperative Nausea and Vomiting | Phase 4 | Status: UNKNOWN